Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy
N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé, N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé
Abstract
There is still controversy concerning the beneficial aspects of 'dynamic analgesia' (i.e. pain while coughing or moving) on the reduction of postoperative atelectasis. In this study, we tested the hypothesis that thoracic epidural analgesia (TEA) prevents these abnormalities as opposed to multimodal analgesia with i.v. patient controlled analgesia (i.v. PCA) after thoracotomy. Fifty-four patients undergoing thoracotomy (lung cancer) were randomly assigned to one of the two groups. Clinical respiratory characteristics, arterial blood gas, and pulmonary function tests (forced vital capacity and forced expiratory volume in 1 s) were obtained before surgery and on the next 3 postoperative days. Atelectasis was compared between the two groups by performing computed tomography (CT) scan of the chest at day 3. Postoperative respiratory function and arterial blood gas values were reduced compared with preoperative values (mean (SD) FEV1 day 0: 1.1 (0.3) litre; 1.3 (0.4) litre) but there was no significant difference between groups at any time. PCA and TEA provided a good level of analgesia at rest (VAS day 0: 21 (15/100); 8 (9/100)), but TEA was more effective for analgesia during mobilization (VAS day 0: 52 (3/100); 25 (17/100)). CT scans revealed comparable amounts of atelectasis (expressed as a percentage of total lung volume) in the TEA (7.1 (2.8)%) and in the i.v. PCA group (6.71 (3.2)%). There was no statistical difference in the number of patients presenting with at least one atelectasis of various types (lamellar, plate, segmental, lobar).
Source: PubMed
今後の臨床試験
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied Practiceまだ募集していません
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCまだ募集していません
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata Veronaまだ募集していません
-
University of Wisconsin, MadisonAlkermes, Inc.まだ募集していません
-
Virginia Commonwealth Universityまだ募集していません
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinaiまだ募集していませんケタミン | fMRI | うつ病 - 大うつ病性障害 | rTMS | 治療抵抗性うつ病 (TRD)アメリカ
-
Weill Medical College of Cornell UniversityBD2 LLCまだ募集していませんfMRI | 双極性障害(BD) | rTMS | 双極1うつ病アメリカ
-
Yale UniversityNational Institute of Mental Health (NIMH)まだ募集していません
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge募集褐色細胞腫 | 褐色細胞腫/傍神経節腫 | 褐色細胞腫、転移性 | 悪性褐色細胞腫 | 褐色細胞腫および傍節腫(PPGL)イギリス
-
Carl Zeiss Meditec-Dublin CoCe募集網膜上膜 | 網膜疾患 | 乾燥性加齢黄斑変性症 | 硝子体網膜異常 | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium (RPE) Atrophyアメリカ
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical University募集